Artificial expression constructs for modulating gene expression in claustrum neurons
AssigneeAllen Institute
InventorsTanya Daigle, Lucas T. Graybuck, Adriana Estela Sedeño Cortés, Bosiljka Tasic, Jonathan Ting
Life of this patent
Estimating the term…
Abstract
Artificial expression constructs for modulating gene expression in targeted central nervous system cell types are described. The artificial expression constructs can be used to express synthetic genes or modify gene expression in claustrum neurons including L6 IT Car3 neurons.
Claims73
An artificial expression construct comprising (i) an MGT_E51 enhancer having the sequence as set forth in SEQ ID NO:
- 1 or a sequence having at least 90% sequence identity to the sequence as set forth in SEQ ID NO:
- 1;
- (ii) a promoter;
- and (iii) a heterologous coding sequence.
A concatenated core of an eHGT_774m, eHGT_772m, or eHGT486m enhancer.
An artificial expression construct comprising (i) an enhancer selected from MGT_E51, MGT_E52, MGT_E57, eHGT_770m, eHGT_774m, eHGT_772m, eHGT_486m, eHGT_875m, eHGT_923m, eHGT_924m, eHGT_925m, eHGT_926m, 3xcore2_eHGT_774m, 3xcore2_eHGT_772m, and/or 3xCore_eHGT486m;
- (ii) a promoter;
- and (iii) a heterologous coding sequence.
An adeno-associated viral (AAV) vector comprising at least one heterologous coding sequence, wherein the heterologous coding sequence is under the transcriptional control of a promoter and an enhancer selected from MGT_E51, MGT_E52, MGT_E57, eHGT_770m, eHGT_774m, eHGT_772m, eHGT_486m, eHGT_875m, eHGT_923m, eHGT_924m, eHGT_925m, eHGT_926m, 3xcore2_eHGT_774m, 3xcore2_eHGT_772m, and 3xCore_eHGT486m.
The method of claim 71, wherein the injection comprises intravenous injection, intraparenchymal injection into brain tissue, intracerebroventricular (ICV) injection, intra-cisterna magna (ICM) injection, or intrathecal injection.
An artificial expression construct consisting of or consisting essentially of a sequence as set forth in SEQ ID NO:
- 41, SEQ ID NO:
- 69, SEQ ID NO:
- 42, SEQ ID NO:43, SEQ ID NO:
- 44, SEQ ID NO:
- 45, SEQ ID NO:
- 46, SEQ ID NO:
- 47, SEQ ID NO:
- 68, SEQ ID NO:70, SEQ ID NO:
- 71, SEQ ID NO:
- 72, SEQ ID NO:
- 73, SEQ ID NO:
- 74, SEQ ID NO:
- 75, SEQ ID NO:
- 76, SEQ ID NO:
- 77, SEQ ID NO:
- 78, or SEQ ID NO:
- 79 or a sequence having at least 90% sequence identity to a sequence as set forth in SEQ ID NO:
- 41, SEQ ID NO:
- 69, SEQ ID NO:
- 42, SEQ ID NO:43, SEQ ID NO:
- 44, SEQ ID NO:
- 45, SEQ ID NO:
- 46, SEQ ID NO:
- 47, SEQ ID NO:
- 68, SEQ ID NO:70, SEQ ID NO:
- 71, SEQ ID NO:
- 72, SEQ ID NO:
- 73, SEQ ID NO:
- 74, SEQ ID NO:
- 75, SEQ ID NO:
- 76, SEQ ID NO:
- 77, SEQ ID NO:
- 78, or SEQ ID NO:
- 79.
Dependencies are inferred from the claim text.